Back to search

Article

The Response of Second Line Chemotherapy Platinum Resistant Ovarian Cancer in Sudan: 2013-2017

2019-08-20

Abstract excerpt

<title>Abstract</title> <p>Background Ovarian carcinoma is the fifth leading cause of cancer death worldwide. The tumor mostly associated with variant factors such as advance age, early menstruation and gene association. We aimed to highlight the effectiveness of the second line chemotherapy in the management of ovarian cancer patients in Sudan.Methods The data were collected from the hospital patient’s records...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1dc0e1f7-dedf-56fb-98e1-c045ee749cb3
DOI
10.21203/rs.2.13192/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Response of Second Line Chemotherapy Platinum Resistant Ovarian Cancer in Sudan: 2013-2017DOI 10.21203/rs.2.13192/v1
The Response of Second Line Chemotherapy Platinum Resistant Ovarian Cancer in Sudan: 2013-2017Semantic proximity
Actualities in Ovarian Cancer in the Perspective of 2015 (ASCO and ECCO).Semantic proximity
Biomarkers of drug resistance in ovarian cancerSemantic proximity
Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian CancersSemantic proximity
[Natural history of ovary cancer].Semantic proximity
Apatinib in Treating Clinical and Biochemical Recurrent Ovarian CancerSemantic proximity
Immunohistochemical expression of p53 in Type I and II epithelial ovarian cancer among Sudanese women: a cross-sectional studySemantic proximity
Newly diagnosed ovarian cancer: Which first-line treatment?Semantic proximity
Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New SolutionsSemantic proximity
Successful maintenance therapy with apatinib inplatinum-resistant advanced ovarian cancer and literature review.Semantic proximity
Generation of Cisplatin-Resistant Ovarian Cancer Cell LinesSemantic proximity
Select a neighboring publication to make it the new centre.